- Home
- ONB vs QGEN Comparison
ONB vs QGEN Comparison
Compare ONB & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- QGEN
- Stock Information
- Founded
- ONB 1834
- QGEN 1986
- Country
- ONB United States
- QGEN Netherlands
- Employees
- ONB N/A
- QGEN N/A
- Industry
- ONB Major Banks
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONB Finance
- QGEN Health Care
- Exchange
- ONB Nasdaq
- QGEN Nasdaq
- Market Cap
- ONB 7.9B
- QGEN 9.1B
- IPO Year
- ONB N/A
- QGEN 1996
- Fundamental
- Price
- ONB $20.86
- QGEN $45.14
- Analyst Decision
- ONB Buy
- QGEN Buy
- Analyst Count
- ONB 9
- QGEN 8
- Target Price
- ONB $26.11
- QGEN $50.53
- AVG Volume (30 Days)
- ONB 3.7M
- QGEN 1.5M
- Earning Date
- ONB 07-22-2025
- QGEN 05-07-2025
- Dividend Yield
- ONB 2.69%
- QGEN 2.92%
- EPS Growth
- ONB N/A
- QGEN N/A
- EPS
- ONB 1.72
- QGEN 0.42
- Revenue
- ONB $1,795,802,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- ONB $44.42
- QGEN $6.11
- Revenue Next Year
- ONB $16.19
- QGEN $6.10
- P/E Ratio
- ONB $12.14
- QGEN $107.32
- Revenue Growth
- ONB 3.29
- QGEN 3.31
- 52 Week Low
- ONB $15.60
- QGEN $37.63
- 52 Week High
- ONB $24.49
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- ONB 46.80
- QGEN 66.03
- Support Level
- ONB $20.17
- QGEN $41.77
- Resistance Level
- ONB $21.62
- QGEN $43.01
- Average True Range (ATR)
- ONB 0.49
- QGEN 0.70
- MACD
- ONB -0.13
- QGEN 0.24
- Stochastic Oscillator
- ONB 27.27
- QGEN 93.82
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).